Industry Experts

Dr. Daniel Benjamin is the Chief Technology Officer and co-founder of Immuto Scientific, where he leads the development and application of the company’s proprietary structural biology platform. As one of the inventors of Immuto’s core technology, he guided its design and engineering from early research through commercial implementation. His doctoral work pioneered the use of plasma-based protein footprinting to capture high-resolution structural insights in native environments. Today, Dr. Benjamin focuses on translating these capabilities into therapeutic discovery, enabling rational antibody design against challenging disease targets and advancing collaborations that bring precision and speed to the front end of drug discovery.